Germline deletion of AMP-activated protein kinase β subunits reduces bone mass without altering osteoclast differentiation or function

IL-23 Inhibits Osteoclastogenesis Indirectly through Lymphocytes and Is Required for the Maintenance of Bone Mass in Mice

(2014) J. M. W. Quinn et al.   JOURNAL OF IMMUNOLOGY

AMPK/SNF1 structure: a menage a trois of energy-sensing

(2009) John et al.   Frontiers in Bioscience-Landmark

Use of Thiazolidinediones and Fracture Risk

(2008) Christian Meier et al.   ARCHIVES OF INTERNAL MEDICINE

AMPK and PPARδ Agonists Are Exercise Mimetics

(2008) Vihang A. Narkar et al.   CELL

Thienopyridone Drugs Are Selective Activators of AMP-Activated Protein Kinase β1-Containing Complexes

(2008) John W. Scott et al.   CHEMISTRY & BIOLOGY

Acadesine, an adenosine-regulating agent with the potential for widespread indications

(2008) Brian G Drew et al.   EXPERT OPINION ON PHARMACOTHERAPY

Rosiglitazone Stimulates Nitric Oxide Synthesis in Human Aortic Endothelial Cells via AMP-activated Protein Kinase

(2008) James G. Boyle et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Cardiotrophin-1 Is an Osteoclast-Derived Stimulus of Bone Formation Required for Normal Bone Remodeling

(2008) Emma C Walker et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Transdermal Lovastatin Enhances Fracture Repair in Rats

(2008) Gloria E Gutierrez et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Association of Pioglitazone Treatment with Decreased Bone Mineral Density in Obese Premenopausal Patients with Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Trial

(2008) Dorte Glintborg et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Molecular mechanisms of inflammatory bone damage: emerging targets for therapy

(2008) Sonja Herman et al.   TRENDS IN MOLECULAR MEDICINE